Duncan Gilmour
Analyst · Northland Securities. Please go ahead
Thank you, Nick. Starting on Slide five. As Nick noted, revenue for the second quarter was $34 million, including $9.7 million from Alfamation. The $1.4 million increase compared with Q2 2023 was driven by $9.2 million of sales growth in Auto/EV primarily from the acquisition. This more than offset the $8.7 million sales decline in semi. Sequentially, second quarter revenue increased $4.2 million, with Auto/EV up $6.8 million and Life Sciences up $1.5 million. Both markets benefited from the acquisition. Semi revenue fell 32% or $4.8 million. Revenue from Alfamation more than offset that decline. Moving to Slide six. Gross margin of 40.6% for the quarter contracted 325 basis points sequentially, driven by product mix. On a year-over-year comparison, gross margin contraction was also significantly impacted by product mix with lower volume on our higher-margin semi business being offset with lower margin revenue from the acquisition. On a trailing 12-month basis, our gross profit was $53.8 million or 43.8% of sales, the drop reflecting the weakness in higher-margin semi sales. As you can see on Slide seven, compared with the prior year, our operating expenses were up $1.8 million as we incorporated a full quarter of the acquisition’s operating expenses. Sequentially, cost reductions during the quarter lowered legacy business OpEx by nearly $1 million and partially offset the $2 million sequential increase from the acquisition. As a reminder, Q2 incorporated a full quarter of acquisition operating costs, whereas Q1 included just over two weeks. Sequentially, while operating expenses in total were up $870,000 as a percent of sales, the decline was 260 basis points to 39.6%. Turning to Slide eight, you can see our bottom line and adjusted EBITDA results. For the quarter, net earnings were $230,000 or $0.02 per diluted share. Adjusted net earnings were $959,000 or $0.08 per diluted share. Adjusted EPS reflects adding back tax-effected acquired intangible amortization. On an after-tax basis, our acquired intangible amortization amounted to approximately $729,000 or about $0.06 per diluted share in the second quarter. Adjusted EBITDA for Q2 was $2.2 million, representing a 6.3% adjusted EBITDA margin. Slide nine shows our capital structure and cash flow. With a ramp in shipments towards the end of the quarter, combined with cash outflows for 2023 bonus payments and first half 2024 estimated tax payments, we used $5.1 million of operating cash during the quarter. Capital expenditures in the second quarter were approximately $300,000 unchanged from the prior year period and the resultant free cash outflow was $5.4 million. Cash and equivalents at the end of the second quarter were $20.4 million, down $7 million from the trailing quarter, reflecting free cash outflow combined with net debt repayments and foreign exchange impacts. We ended the quarter with total debt of $21.1 million. This reflects a total debt leverage ratio of 2.1x. During the quarter, we repaid approximately $1.1 million of debt. We continue to have $30 million available with our delayed draw term loan and incremental $10 million available under our revolver. As a reminder, in May, we extended the maturity date on these facilities by 4 years to May 2031 and the drawdown period was extended two years to May 2026. Turn to Slide 10 as we review our outlook for 2024. For the third quarter, we are expecting revenue to be slightly lower than the second quarter with gross margins improving somewhat. Third quarter operating expenses, including amortization, are expected to be similar to Q2, total intangible asset amortization is expected to be approximately $900,000 and approximately $700,000 after tax or about $0.06 per share. We are expecting EPS and adjusted EPS for the third quarter to be similar to the second quarter. As a reminder, we simply adjust for tax-effected amortization expense. We have updated our full year outlook to reflect the market conditions and recent order trends, Nick discussed. We now expect 2024 revenue to range from $128 million to $133 million. Gross margin for 2024 is expected to be approximately 42% to 43% with expected operating expenses of approximately $54 million. This includes intangible asset amortization expense of approximately $3.3 million or $2.7 million on a tax-adjusted basis. Our expected effective tax rate remains at about 17% to 19%. We still expect our capital expenditures in 2024 to run between 1% to 2% of sales. As usual, our guidance does not include the potential impact from any non-operating expenses such as corporate development that may occur from time to time, nor does it include the potential impact from any additional acquisitions we may make. With that, if you will turn to Slide 11, I will now turn the call back over to Nick.